Marissa Rybstein
Impact in
-
- interferon and immune responses
- Immunotherapy and Immune Responses
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Epigenetics and DNA Methylation 2
- PI3K/AKT/mTOR signaling in cancer 2
- Oncology 4
- Co-authors
- Lorenzo Galluzzi (4 shared papers)Guido Kroemer (1 shared paper)José Manuel Bravo‐San Pedro (1 shared paper)Meena Jhanwar‐Uniyal (3 shared papers)Raj Murali (3 shared papers)Amanda Kwasnicki (1 shared paper)Ai Sato (3 shared papers)Takahiro Yamazaki (3 shared papers)
- Journals
- Cancer (1 paper)International Journal of Radiation Oncology*Biology*Physics (1 paper)Oncology Reports (1 paper)Clinical Breast Cancer (1 paper)Cancers (1 paper)
- Partner nations
- United StatesSpainFrance
In The Last Decade
Marissa Rybstein
16 papers receiving 796 citations
Peers
Comparison fields: 5 of 101
- Immunology 215
- Oncology 246
- Cancer Research 134
- Physiology 29
- Genetics 67
Countries citing papers authored by Marissa Rybstein
This map shows the geographic impact of Marissa Rybstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marissa Rybstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marissa Rybstein more than expected).
Fields of papers citing papers by Marissa Rybstein
This network shows the impact of papers produced by Marissa Rybstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marissa Rybstein. The network helps show where Marissa Rybstein may publish in the future.
Co-authors
The 25 scholars most cited alongside Marissa Rybstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 234 | |
| 2 | 2018 | 224 | |
| 3 | 2015 | 107 | |
| 4 | 2020 | 84 | |
| 5 | 2013 | 45 | |
| 6 | 2021 | 25 | |
| 7 | PI3K/mTOR signaling pathways in medulloblastoma. | 2012 | 19 |
| 8 | 2023 | 14 | |
| 9 | Risk factors for and clinical management of venous thromboembolism during pregnancy. | 2019 | 14 |
| 10 | 2018 | 13 | |
| 11 | 2019 | 8 | |
| 12 | 2015 | 6 | |
| 13 | 2019 | 4 | |
| 14 | 2022 | 2 | |
| 15 | Handbook of Pediatric Infectious Diseases | 1987 | 2 |
| 16 | 2021 | 2 | |
| 17 | 2023 | 1 | |
| 18 | 2024 | 0 |
About Marissa Rybstein
Marissa Rybstein is a scholar working on Molecular Biology, Oncology, Immunology, Genetics and Epidemiology, having authored 18 papers that have together received 804 indexed citations. Recurring topics across this work include Autophagy in Disease and Therapy (3 papers), Epigenetics and DNA Methylation (2 papers), Head and Neck Cancer Studies (2 papers), interferon and immune responses (2 papers), Advanced Radiotherapy Techniques (2 papers), Venous Thromboembolism Diagnosis and Management (2 papers), Blood Coagulation and Thrombosis Mechanisms (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). The work is most often cited by research in Immunology (215 citations), Oncology (246 citations), Cancer Research (134 citations), Physiology (29 citations) and Genetics (67 citations). Marissa Rybstein has collaborated with scholars based in United States, Spain and France. Frequent co-authors include Lorenzo Galluzzi, Guido Kroemer, José Manuel Bravo‐San Pedro, Meena Jhanwar‐Uniyal, Raj Murali, Amanda Kwasnicki, Ai Sato, Takahiro Yamazaki, Aitziber Buqué and Francesca Finotello. Their work appears in journals such as Cancer, International Journal of Radiation Oncology*Biology*Physics, Oncology Reports, Clinical Breast Cancer and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.